Zofia Hélias-Rodzewicz, Jean Donadieu, Nathalie Terrones, Mohamed-Aziz Barkaoui, Anne Lambilliotte, Despina Moshous, Caroline Thomas, Saba Azarnoush, Marlène Pasquet, Ludovic Mansuy, Nathalie Aladjidi, Eric Jeziorski, Perrine Marec-Berard, Marion Gilibert-Yvert, Alexandra Spiegel, Paul Saultier, Isabelle Pellier, Anne Pagnier, Sophie Pertuisel, Maryline Poiree, Damien Bodet, Frédéric Millot, Florentina Isfan, Jean-Louis Stephan, Amaury Leruste, Charlotte Rigaud, Bruno Filhon, Liana Carausu, Yves Reguerre, Isabelle Kieffer, Bénédicte Brichard, Rim Ben Jannet, Mariama Bakari, Ahmed Idbaih, Christine Bodemer, Fleur Cohen-Aubart, Julien Haroche, Abdellatif Tazi, Sabah Boudjemaa, Sylvie Fraitag, Jean-François Emile, Sébastien Heritier
The spectrum of somatic mutations in pediatric histiocytoses and their clinical implications are not fully characterized, especially for non-Langerhans cell histiocytosis (-LCH) subtypes. A cohort of 415 children with histiocytosis from the French histiocytosis registry was reviewed and analyzed for BRAFV600E . Most BRAFWT samples were analyzed by next-generation sequencing (NGS) with a custom panel of genes for histiocytosis and myeloid neoplasia. Of 415 case samples, there were 366 LCH, 1 Erdheim-Chester disease, 21 Rosai-Dorfman disease (RDD), 21 juvenile xanthogranuloma (JXG, mostly with severe presentation), and 6 malignant histiocytosis (MH)...
July 2023: American Journal of Hematology